Cleared Traditional

K152300 - Glucommander

K152300 is an FDA 510(k) clearance for Glucommander, manufactured by Glytec, LLC. The device is a Class 2 General Hospital device with product code NDC cleared through the Traditional 510(k) pathway after a 721-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2017
Decision
721d
Days
Class 2
Risk

K152300 is an FDA 510(k) clearance for the Glucommander. Classified as Calculator, Drug Dose (product code NDC), Class II - Special Controls.

Submitted by Glytec, LLC (Greenville, US). The FDA issued a Cleared decision on August 4, 2017 after a review of 721 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 868.1890 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Glytec, LLC devices

FDA 510(k) Submission Details - K152300

510(k) Number K152300 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 2015
Decision Date August 04, 2017
Days to Decision 721 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
592d slower than avg
Panel avg: 129d · This submission: 721d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NDC Device Classification - Class 2, Special Controls

Product Code NDC Calculator, Drug Dose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - NDC Calculator, Drug Dose

All 42
Devices cleared under the same product code (NDC) and FDA review panel - the closest regulatory comparables to K152300.
Glooko Mobile Insulin Dosing System
K171450 · Glooko, Inc. · Feb 2018
Insulia Diabetes Management Companion
K172177 · Voluntis Sa. · Nov 2017
Health-e-Connect System with IDA
K163664 · Alr Technologies · Sep 2017
Insulia Diabetes Management Companion
K170669 · Voluntis Sa. · Jun 2017
Insulin Algorithms System
K160673 · Insulin Algorithms · Jun 2017
My Dose Coach
K171230 · Sanofi · May 2017